These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7111064)

  • 21. Serum vitamin E and fatty acid composition of the red cell membrane phospholipids in patients with chronic renal failure treated by hemodialysis.
    Heldenberg D; Blum M; Levtow O; Maisner I
    Clin Nephrol; 1982 Nov; 18(5):272. PubMed ID: 7151344
    [No Abstract]   [Full Text] [Related]  

  • 22. Taste disorders present in patients with chronic renal failure do not have an effect on overhydration and excessive weight gain between dialyses.
    Bohatyrewicz M; Borowiecka E; Ciechanowski K
    Nephrology (Carlton); 2005 Jun; 10(3):274-5. PubMed ID: 15958041
    [No Abstract]   [Full Text] [Related]  

  • 23. Cell cholesterol transport to plasma in blood from patients with renal failure or a kidney transplant.
    Sutherland WH; Corboy J; Walker RJ; Robertson MC; Ball MJ
    Nephrol Dial Transplant; 1995; 10(3):358-65. PubMed ID: 7792031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Electrolyte studies on erythrocytes in chronic renal insufficiency prior to and following hemodialysis using diclysates with varying electrolyte concentration].
    Hagemann I; Schilling E; Precht K; Strangfeld D; Lindenau K; Kruse I; Pietsch R; Hörold I
    Z Urol Nephrol; 1976 Dec; 69(12):901-5. PubMed ID: 1014933
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients.
    Vanholder R; Camez A; Veys N; Van Loo A; Dhondt AM; Ringoir S
    Thromb Haemost; 1997 Apr; 77(4):650-5. PubMed ID: 9134637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Observation of intraocular pressure in patients treated with dialyses for terminal renal failure (author's transl)].
    Dyszyńska-Rościszewska B; Moszczyńska-Kowalska A; Dróbecka-Brydakowa E; Szretter K; Klepacka J
    Klin Oczna; 1979 Nov; 81(11):613-6. PubMed ID: 537308
    [No Abstract]   [Full Text] [Related]  

  • 27. Does glucose in dialysis fluid protect erythrocytes in patients with chronic renal failure?
    Dolegowska B; Stepniewska J; Ciechanowski K; Safranow K; Millo B; Bober J; Chlubek D
    Blood Purif; 2007; 25(5-6):422-9. PubMed ID: 17938567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Physico-chemical properties of the blood of patients with chronic kidney failure].
    Gromov AE; Kulikova AI; Shostka GD; Tugusheva FA; Lukichev BG
    Vopr Med Khim; 1982; 28(6):20-4. PubMed ID: 7157718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma human brain natriuretic peptide in chronic renal failure.
    Akiba T; Tachibana K; Togashi K; Hiroe M; Marumo F
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S61-4. PubMed ID: 8608666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Products of lipid peroxidation in the blood plasma of patients with chronic renal insufficiency treated with hemodialysis].
    Nikiforova NV; Sokolovskaia IV
    Ter Arkh; 1980; 52(4):55-7. PubMed ID: 7404338
    [No Abstract]   [Full Text] [Related]  

  • 31. Alterations of erythrocyte structure and cellular susceptibility in patients with chronic renal failure: effect of haemodialysis and oxidative stress.
    Brzeszczynska J; Luciak M; Gwozdzinski K
    Free Radic Res; 2008 Jan; 42(1):40-8. PubMed ID: 18324522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of hemodialysis on the deformability and lipid peroxidation of erythrocytes in chronic renal failure.
    Szikszai Z; Ujhelyi L; Imre SG
    Clin Hemorheol Microcirc; 2003; 28(4):201-7. PubMed ID: 12897411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour markers in chronic renal failure and haemodialysis patients.
    Eskiocak S; Dortok H; Alvur M; Cengiz K
    Nephrol Dial Transplant; 1995; 10(7):1256. PubMed ID: 7478140
    [No Abstract]   [Full Text] [Related]  

  • 34. [Von Willebrand factor in hemodialysed patients with chronic renal failure].
    Bronisz M; Rość D; Paczuski R; Nartowicz E; Bronisz A
    Pol Merkur Lekarski; 2001 Jul; 11(61):40-3. PubMed ID: 11579829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute copper intoxication. A hazard of hemodialysis.
    Klein WJ; Metz EN; Price AR
    Arch Intern Med; 1972 Apr; 129(4):578-82. PubMed ID: 5019446
    [No Abstract]   [Full Text] [Related]  

  • 36. [Liver function tests in patients with terminal renal failure treated conservatively and with repeated hemodialysis].
    Smoleński O; Caban M; Kutrzeba W
    Pol Tyg Lek; 1980 Feb; 35(8):273-5. PubMed ID: 7360704
    [No Abstract]   [Full Text] [Related]  

  • 37. [Peritoneal dialysis in the treatment of chronic renal failure].
    Kazimirov VG; Butrin SV; Bekov RR; Sapozhnikov AD; Kharitonov BI; Smoliakov AM; Detinenko IN
    Urologiia; 2004; (5):58-62. PubMed ID: 15560166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythrocyte glutathione peroxidase and superoxide dismutase activities in different stages of chronic renal failure.
    Mimic-Oka J; Simic T; Ekmescic V; Dragicevic P
    Clin Nephrol; 1995 Jul; 44(1):44-8. PubMed ID: 7554532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Concentration of selected trace elements in the blood of patients with chronic renal failure].
    Adamiec R; Weyde W
    Pol Tyg Lek; 1982 Dec; 37(48):1421-4. PubMed ID: 7183997
    [No Abstract]   [Full Text] [Related]  

  • 40. [An evaluation of the oral administration of essential amino acids to patients treated by lasting dialysis (author's transl)].
    Prejac M; Jeren-Struić B; Straus B; Vitunjski B; Kovarbasić B; Kozjak D
    Lijec Vjesn; 1981 Dec; 103(12):555-60. PubMed ID: 7345322
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.